Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fluvastatin affects HLA class I expression on endothelial cells].

Guillaume Belliard1, Stéphanie Coupel, Béatrice Charreau

  • 1Institut national de la santé et de la recherche médicale, UMR 643, Immunointervention en allo et xénotransplantation, et institut de transplantation et de recherche en transplantation, CHU Hôtel-Dieu, 44093 Nantes cedex 01, France.

Nephrologie & Therapeutique
|August 10, 2006
PubMed
Summary

Statins like fluvastatin can alter immune responses in endothelial cells (ECs). This study found fluvastatin upregulates MHC class I and downregulates MHC class II expression on ECs, potentially impacting vascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of Kidney Allograft Rejection Using Urinary Chemokines.

Journal of the American Society of Nephrology : JASN·2025
Same author

Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection.

European journal of epidemiology·2024
Same author

The combination of kidney function variables with cell cycle arrest biomarkers identifies distinct subphenotypes of sepsis-associated acute kidney injury: a <i>post-hoc</i> analysis (the PHENAKI study).

Renal failure·2024
Same author

Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.

Frontiers in immunology·2023
Same author

Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.

Cells·2023
Same author

Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C<sup>+</sup>CD57<sup>+</sup>NK and δ2<sup>-</sup>γδT cell subsets.

Frontiers in immunology·2022

Area of Science:

  • Immunology
  • Vascular Biology
  • Pharmacology

Background:

  • Statins, traditionally used for lipid management in atherosclerosis, may possess anti-inflammatory and immunomodulatory effects.
  • Previous research indicates statins can reduce MHC class II and CD40 expression on activated endothelial cells (ECs).

Purpose of the Study:

  • To investigate the impact of fluvastatin on Major Histocompatibility Complex (MHC) class I expression and regulation in human ECs.
  • To examine fluvastatin's effects on ECs in response to interferon-gamma (IFNγ).

Main Methods:

  • Primary human EC cultures were treated with varying doses of fluvastatin (0.01, 0.1, 1 µM) ± IFNγ for 48 hours.
  • Surface expression of MHC class I and class II was quantified using flow cytometry.
  • Reversal of effects was assessed using mevalonate.

Related Experiment Videos

Main Results:

  • Fluvastatin demonstrated a dose-dependent increase in MHC class I expression on quiescent ECs.
  • Fluvastatin enhanced IFNγ-induced MHC class I upregulation.
  • Fluvastatin inhibited IFNγ-induced MHC class II expression.
  • These statin-induced changes were reversible by mevalonate.

Conclusions:

  • Fluvastatin modulates MHC expression on ECs, upregulating MHC class I while downregulating MHC class II.
  • These findings suggest a potential role for statins in regulating immune responses within the vasculature.
  • Further in vitro and in vivo studies are needed to determine the functional significance of these statin-mediated MHC alterations on ECs.